Mbs-D-Arg-OH

Mbs-D-Arg-OH is an Mbs-protected D-arginine amino acid, where the D-configured α-stereocenter and the guanidinium-bearing side chain are central to its reactivity and peptide compatibility. The Mbs group on the side-chain nitrogen provides a protected arginine functionality that can be carried through coupling steps while controlling chemoselectivity toward the guanidinium moiety. The free carboxylic acid enables C-terminal incorporation into peptide chains, and the protected side chain supports downstream deprotection strategies to regenerate the strongly basic guanidine for salt formation and biomolecular recognition. The combination of a stereodefined amino acid core and a protected, charge-delocalized guanidinium precursor makes this compound a practical chiral intermediate for peptide construction, chemical biology probes, and industrial amino acid derivative synthesis workflows.

1. Peptide Synthesis

Mbs-D-Arg-OH is used in peptide building workflows where arginine side-chain chemistry must be protected during amide bond formation. The protected guanidinium functionality and the D-configuration at the α-carbon support controlled peptide coupling at the carboxylic acid, while the Mbs group helps manage side-chain reactivity and minimizes undesired side reactions during standard peptide assembly. The resulting D-arginine-containing peptide segments can be carried forward for later guanidinium unmasking to restore the basic side chain for electrostatic interactions and receptor-binding motifs. Peptide synthesis compatibility makes Mbs-D-Arg-OH suitable for generating D-amino acid enriched sequences, peptidomimetic scaffolds, and stereochemically defined analog libraries used in structure-function studies.

2. Unnatural Amino Acid Incorporation

Mbs-D-Arg-OH serves as a stereodefined chiral building block for unnatural amino acid incorporation strategies that require D-arginine placement within peptide or peptidomimetic frameworks. The side-chain guanidine architecture, protected as an Mbs derivative, can be introduced without exposing the strongly basic functionality during coupling, enabling predictable assembly of D-arginine-containing constructs. Stereochemical control is maintained by the D-configuration, which can influence backbone conformation, protease stability, and binding-site geometry in downstream molecular designs. Incorporation of this amino acid analog supports the generation of stereochemically resolved peptide variants for biochemical research intermediate preparation and for synthetic methodology development involving D-amino acid chemistry.

3. Side-Chain Functionalization

Mbs-D-Arg-OH is applied in chemical modification routes where arginine side-chain behavior is leveraged after controlled deprotection and derivatization. The Mbs-protected guanidinium precursor allows the protected arginine to be handled under peptide synthesis conditions, then converted to the free guanidine for subsequent salt formation, hydrogen-bonding interactions, or targeted functional group transformations. The presence of a free carboxylic acid also enables further derivatization as a C-terminal handle for conversion into activated esters or amide-linked intermediates used in probe or intermediate synthesis. Side-chain functionalization utility supports downstream formation of charged biomolecule mimics, affinity reagents, and chemically defined amino acid derivatives used in applied peptide science and industrial fine chemical synthesis.

4. Bioconjugation Chemistry

Mbs-D-Arg-OH is suitable for bioconjugation workflows that require incorporation of an arginine-like, strongly basic motif into labeled or immobilized biomolecular constructs. The protected guanidinium functionality helps maintain chemoselectivity during conjugation assembly, while the D-arginine stereochemistry can be used to tune interaction profiles and stability of the conjugate scaffold. The carboxylic acid functionality supports coupling strategies that connect the amino acid or peptide fragment to linkers, tags, or carrier molecules, with later guanidinium unmasking enabling charge-driven binding and improved solubility of conjugates. Bioconjugation-oriented use of Mbs-D-Arg-OH supports generation of stereochemically defined labeling intermediates and chemically characterized conjugate components for biochemical research and applied molecular engineering.

5. Pharmaceutical Intermediate Preparation

Mbs-D-Arg-OH is employed as a chiral amino acid intermediate in pharmaceutical and specialty chemical manufacturing contexts where D-amino acid content and protected side-chain handling are required for controlled synthesis. The protected arginine guanidine and the free carboxylic acid enable stepwise synthesis of peptide-like intermediates, allowing manufacturing routes to incorporate D-arginine units while deferring guanidinium exposure until appropriate processing stages. The stereochemical integrity of the D-configuration supports the production of stereodefined building blocks used in peptidomimetic construction and SAR-focused intermediate generation. Industrial relevance arises from its role as a defined, protected amino acid input for process chemistry intermediate preparation, enabling downstream conversion into larger protected fragments and final unmasked arginine-containing targets for chemical manufacturing workflows.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation